EP
| |
Eversept Partners, LP13F | |
| Eversept Partners, LP | |
| Last update 2025-05-15 | 57 Stocks (11 new) |
| Value $985.00 Mil | Turnover 23 % |
Eversept Partners, LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTRA | Natera Inc | 893,721 | 126,381.1 | +1.93% | 12.830 | +0.24% | 0.650 | +0.31% | -9.87% | 19,481.1 | Medical Diagnostics & Research | |
GSK | GSK PLC | 2,623,246 | 101,624.6 | -28.36% | 10.320 | -3.12% | 0.130 | +1.43% | +10.54% | 73,817.1 | Drug Manufacturers | |
QQQ
PUT
| INVESCO QQQ Trust | 123,600 | 57,958.5 | 0% | 5.890 | 0% | 0.020 | +30.70% | +10.90% | 360,452.5 | ||
HCA | HCA Healthcare Inc | 152,502 | 52,697.1 | -13.26% | 5.350 | -0.62% | 0.060 | +14.88% | +21.84% | 87,609.8 | Healthcare Providers & Services | |
SNDX | Syndax Pharmaceuticals Inc | 4,212,270 | 51,747.7 | +1,126.64% | 5.260 | +4.83% | 4.900 | -19.11% | -27.00% | 830.4 | Biotechnology | |
VERA | Vera Therapeutics Inc | 1,898,804 | 45,609.3 | +18.67% | 4.630 | +0.73% | 2.980 | +8.05% | -46.06% | 1,454.7 | Biotechnology | |
SPY
PUT
| SPDR S&P 500 ETF Trust | 76,900 | 43,017.1 | 0% | 4.370 | 0% | 0.010 | +23.25% | +8.39% | 647,292.4 | ||
RVTY | Revvity Inc | 299,087 | 31,643.4 | -23.80% | 3.210 | -0.93% | 0.250 | +2.62% | -17.35% | 10,850.5 | Medical Diagnostics & Research | |
HQY | HealthEquity Inc | 351,976 | 31,104.1 | -8.98% | 3.160 | -0.30% | 0.410 | +21.75% | +1.76% | 8,443.5 | Healthcare Providers & Services | |
INSP | Inspire Medical Systems Inc | 186,425 | 29,693.8 | -36.66% | 3.020 | -1.77% | 0.630 | -12.13% | -31.41% | 3,750.2 | Medical Devices & Instruments |
Eversept Partners, LP's Historical Top Holdings Breakdowns
Eversept Partners, LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | 2025-03-31 | Add Add | +4.83% | 12.29 ($14.1) 16.38 | $9.81 | -30.45% | Add 1126.64% | 4,212,270 | 3,868,870 | |
GSK | GSK PLC | 2025-03-31 | Reduce Reduce | -3.12% | 32.08 ($36.61) 40.39 | $36.54 | -0.18% | Reduce -28.36% | 2,623,246 | -1,038,522 | |
NBIX | Neurocrine Biosciences Inc | 2025-03-31 | New Buy New Buy | +1.88% | 107.22 ($126.68) 153.29 | $132.06 | 4.25% | New holding | 167,243 | 167,243 | |
INSP | Inspire Medical Systems Inc | 2025-03-31 | Reduce Reduce | -1.77% | 157.24 ($180.91) 215.42 | $127.15 | -29.72% | Reduce -36.66% | 186,425 | -107,877 | |
PCVX | Vaxcyte Inc | 2025-03-31 | Add Add | +1.65% | 37.76 ($79.95) 92.13 | $36.77 | -54.02% | Add 336.62% | 557,070 | 429,482 | |
TEVA | Teva Pharmaceutical Industries Ltd | 2025-03-31 | Reduce Reduce | -1.63% | 14.67 ($17.86) 22.01 | $16.40 | -8.17% | Reduce -37.08% | 1,410,765 | -831,360 | |
GKOS | Glaukos Corp | 2025-03-31 | New Buy New Buy | +1.59% | 96.6 ($133.38) 161.22 | $97.91 | -26.59% | New holding | 158,957 | 158,957 | |
CYH | Community Health Systems Inc | 2025-03-31 | Add Add | +1.54% | 2.54 ($3.11) 3.92 | $3.71 | 19.45% | Add 199.19% | 8,458,020 | 5,631,020 | |
GMED | Globus Medical Inc | 2025-03-31 | New Buy New Buy | +1.43% | 69.68 ($82.63) 93.32 | $53.08 | -35.76% | New holding | 192,893 | 192,893 | |
VTRS | Viatris Inc | 2025-03-31 | Sold Out Sold Out | -1.41% | 8.68 ($10.5) 12.42 | $8.96 | -14.71% | Sold Out | 0 | -1,272,102 |
Eversept Partners, LP Total Holding History ($B)
Eversept Partners, LP's Asset Allocation
Eversept Partners, LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Eversept Partners, LP's Hypothetical Growth since 2025-03-31
Eversept Partners, LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Eversept Partners, LP's Holdings Heat Map
Size field:
Eversept Partners, LP's Holdings Bubble Chart
Eversept Partners, LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers